Stephan Urban

The replication cycle of hepatitis B virus.

Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.

Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.

Entry of hepatitis B and C viruses - recent progress and future impact.

NTCP and beyond: opening the door to unveil hepatitis B virus entry.

Strategies to inhibit entry of HBV and HDV into hepatocytes.

Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor.

Hepatitis B Virus Infection of a Mouse Hepatic Cell Line Reconstituted with Human Sodium Taurocholate Cotransporting Polypeptide.

Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications.

Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.

First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B.

Stem cell-derived hepatocytes: A promising novel tool to study hepatitis B virus infection.

HBV DNA Integration: Molecular Mechanisms and Clinical Implications.

Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.

Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes.

Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections.

Editorial overview: Antiviral strategies: Virological and immunological basis for HBV cure.

Cellular Genomic Sites of Hepatitis B Virus DNA Integration.

Sequence analysis of integrated hepatitis B virus DNA during HBeAg-seroconversion.

T5 exonuclease hydrolysis of Hepatitis B Virus replicative intermediates allows reliable quantification and fast drug efficacy testing of covalently closed circular DNA by PCR.